Abstract:A conceptual framework for the identification of prospective aging drug targets. We extracted data about serum protein cis‐pQTLs from three cohorts, and outcomes from the UK Biobank and GWA/GWAS meta‐analysis. After two‐sample Mendelian randomization analysis, Bayesian co‐localization analysis, and summary‐data‐based Mendelian randomization analysis, we identified 10 age‐related proteins as the possible drug targets. Aging represents a multifaceted process culminating in the deterioration of biological functions. Despite the introduction of numerous anti‐aging strategies, their therapeutic outcomes have often been less than optimal. Consequently, discovering new targets to mitigate aging effects is of critical importance. We applied Mendelian randomization (MR) to identify potential pharmacological targets against aging, drawing upon summary statistics from both the Decode and FinnGen cohorts, with further validation in an additional cohort. To address potential reverse causality, bidirectional MR analysis with Steiger filtering was utilized. Additionally, Bayesian co‐localization and phenotype scanning were implemented to investigate previous associations between genetic variants and traits. Summary‐data‐based Mendelian randomization (SMR) analysis was conducted to assess the impact of genetic variants on aging via their effects on protein expression. Additionally, mediation analysis was orchestrated to uncover potential intermediaries in these associations. Finally, we probed the systemic implications of drug‐target protein expression across diverse indications by MR‐PheWas analysis. Utilizing a Bonferroni‐corrected threshold, our MR examination identified 10 protein‐aging associations. Within this cohort of proteins, MST1, LCT, GMPR2, PSMB4, ECM1, EFEMP1, and ISLR2 appear to exacerbate aging risks, while MAX, B3GNT8, and USP8 may exert protective influences. None of these proteins displayed reverse causality except EFEMP1. Bayesian co‐localization inferred shared variants between aging and proteins such as B3GNT8 (rs11670143), ECM1 (rs61819393), and others listed. Mediator analysis pinpointed 1,5‐anhydroglucitol as a partial intermediary in the influence LCT exhibits on telomere length. Circulating proteins play a pivotal role in influencing the aging process, making them promising candidates for therapeutic intervention. The implications of these proteins in aging warrant further investigation in future clinical research.

Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders

Quantitative and Systems Pharmacology. 1. in Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.

A natural product solution to aging and aging-associated diseases

Study of TCM Medication Rules against Aging based on Network Pharmacology and Data Mining

Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation in vivo

Network strategies to understand the aging process and help age-related drug design

Identification of prospective aging drug targets via Mendelian randomization analysis

Systemic mechanism of Panax noteginseng saponins in antiaging based on network pharmacology combined with experimental validation

Methods for the discovery of new anti-aging products – targeted approaches

A Network Pharmacology-based Study on the Anti-aging Properties of Traditional Chinese Medicine Sisheng Bulao Elixir

Natural Products as a Major Source of Candidates for Potential Senolytic Compounds obtained by in silico Screening

Antiaging effects of dietary supplements and natural products

Comprehensive analysis of aging-related gene expression patterns and identification of potential intervention targets

Cross‐species signaling pathways analysis inspire animal model selections for drug screening and target prediction in vascular aging diseases

Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.

Towards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective

Potential implications of natural compounds on aging and metabolic regulation

Current Perspective in the Discovery of Anti-aging Agents from Natural Products

Network pharmacology-based screening of the active ingredients and mechanisms of Huangqi against aging

Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging

Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the mechanism of anti-aging action of Tinospora cordifolia